Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋素是的，很少有炎症能超过急性足痛风的病人了，并且秋素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋疗效果明显转而接受氨苯砜疗的患者应继续服用秋。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋碱治不明显转而接受氨苯砜治的患者应当继续服用秋碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋仙素是不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始秋仙碱治疗效果不明显转氨苯砜治疗的患者应当继续服用秋仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服仙素是不恰当，有炎症能超过急性足痛风病人了，并且仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接仙碱治疗效果不明显转而接氨苯砜治疗患者应当继续服用仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服素是恰当的，很少有炎症能超过急性足痛风的病人了，并且素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受碱治疗效显转而接受氨苯砜治疗的患者应当继续服用碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服仙素是不恰当的，很少有炎症能超过急足痛风的病人了，并且仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋仙素是不恰当的，很少有炎症能超过急性的病人了，并且秋仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

，么你建议，在开始接受秋仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋碱治不明显转而接受氨苯砜治的患者应当继续服用秋碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋仙素是不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋仙碱治疗效果不明显转而接受氨苯砜治疗的患者应当继续服用秋仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋仙素是不恰当，很少有炎症能超过急性足痛风病人了，并且秋仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋仙碱治疗效果不明显转而接受氨苯砜治疗应当继续服用秋仙碱。